LONDON BROKER RATINGS: Morgan Stanley cuts Antofagasta
(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday: Read More
| Price | 570.50p on 05-03-2026 at 06:00:09 |
|---|---|
| Change | 0.00p 0% |
| Buy | 600.00p |
| Sell | 521.00p |
| Last Trade: | Buy 72.00 at 577.85p |
| Day's Volume: | 0 |
| Last Close: | 570.50p |
| Open: | 0.00p |
| ISIN: | GB00BNNTLN49 |
| Day's Range | 0.00p - 0.00p |
| 52wk Range: | 383.00p - 605.50p |
| Market Capitalisation: | £2.69b |
| VWAP: | 0.00p |
| Shares in Issue: | 471.85m |
Pennon (PNN) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 72 | 577.85p | SI Trade Negotiated Trade |
17:08:13 - 04-Mar-26 |
| Buy* | 255 | 570.50p | SI Trade Negotiated Trade |
16:50:13 - 04-Mar-26 |
| Buy* | 3,966 | 575.765p | SI Trade Negotiated Trade |
16:47:10 - 04-Mar-26 |
| Buy* | 3,460 | 570.50p | Automatic Execution |
16:38:11 - 04-Mar-26 |
| Buy* | 844,965 | 570.50p | Suspected BUY Trade |
16:35:13 - 04-Mar-26 |
| Buy* | 602 | 571.50p | Automatic Execution |
16:30:00 - 04-Mar-26 |
| Buy* | 97 | 571.50p | Automatic Execution |
16:30:00 - 04-Mar-26 |
| Buy* | 97 | 571.50p | Automatic Execution |
16:30:00 - 04-Mar-26 |
| Buy* | 97 | 571.50p | Automatic Execution |
16:30:00 - 04-Mar-26 |
| Buy* | 27 | 571.50p | SI Trade |
16:29:36 - 04-Mar-26 |
Pennon (PNN) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 2nd Mar 2026 7:00 am | RNS | Total Voting Rights |
| 23rd Feb 2026 12:58 pm | RNS | Director/PDMR Shareholding |
| 10th Feb 2026 7:00 am | RNS | Confirmation of Chief Executive Officer Start Date |
| 5th Feb 2026 10:58 am | RNS | Holding(s) in Company |
| 2nd Feb 2026 7:01 am | RNS | Total Voting Rights |
| 2nd Feb 2026 7:00 am | RNS | Block listing Interim Review |
| 23rd Jan 2026 3:21 pm | RNS | Director/PDMR Shareholding |
| 2nd Jan 2026 7:00 am | RNS | Total Voting Rights |
| 2nd Jan 2026 7:00 am | RNS | Total Voting Rights |
| 23rd Dec 2025 3:29 pm | RNS | Director/PDMR Shareholding |